Endsulin is using an innovative genetic approach toward developing a potential revolutionary treatment for Type 1 Diabetes.
Our proprietary technology is designed to re-engineer cells in the liver to enable the body to make and regulate its own insulin. We are seeking to create a treatment that will provide long-term results with a single, simple infusion…and without the need for immunosuppressive agents.
Founded by a world-renowned scientist and transplant surgeon and based on years of university research, Endsulin was founded to realize the goal of every diabetes patient: to end dependence on artificial insulin so they can declare their independence from the disease…for good.
